DSHEA Dietary Supplement Regulatory Consulting

🔹 Understanding DSHEA: Why It Matters?

As the FDA implements its Human Foods Program priorities, the margin for error in dietary supplement compliance has disappeared. Heightened oversight of labeling, ingredient safety, and manufacturing practices means that even minor mistakes can now trigger regulatory action.

In 2026, FDA oversight of dietary supplements has entered a new phase. Regulators are no longer focused solely on product labels. Under the “Make America Health Again (MAHA)” agenda and Human Foods Program priorities, enforcement now emphasizes ingredient transparency, chemical safety, and scientific substantiation.

The FDA is actively supporting legislative and administrative efforts toward centralized dietary supplement listing requirements. The proposed Dietary Supplement Listing Act would require manufacturers to register all products in a public database.

The Opportunity
Brands that organize their:

Master Manufacturing Records (MMR)
Batch production records
Ingredient specifications
Product files

now will be best positioned to survive mandatory listing transitions.

🔹Our Compliance Roadmap

We follow a structured, proactive compliance roadmap designed to protect your dietary supplement business before, during, and after FDA oversight. Our approach focuses on prevention, documentation, and continuous monitoring—so your brand remains inspection-ready and enforcement-resistant at all times.

Step 1 — Formula Audit

We begin with a detailed technical review of your product formulations and ingredient profiles. Each ingredient is evaluated against Old Dietary Ingredient (ODI) and New Dietary Ingredient (NDI) classifications, existing regulatory precedents, and available safety data.

We also assess contamination risks, supplier documentation, and testing records to identify potential regulatory red flags early. This step ensures that your product foundation is compliant before moving forward.

You receive a clear regulatory risk assessment for each formulation.

Step 2 — Claim Strategy

Next, we analyze your product claims across labels, websites, advertisements, and marketplace listings. Our team evaluates whether claims remain within permissible “structure/function” boundaries and avoids disease-treatment implications. We help refine your messaging to remain persuasive, competitive, and legally defensible. Scientific substantiation is reviewed where required, and risky language is corrected.

Step 3 — Submission Management

We manage all required electronic submissions through official FDA systems, including NDI notifications, facility records, and compliance filings. Each submission is prepared according to current technical and formatting standards. Our team verifies accuracy, completeness, and consistency across all regulatory entries before filing. We also maintain secure archives of all submission confirmations and correspondence.

Step 4 — Documentation Alignment

We organize and align your internal quality, manufacturing, and regulatory documentation to meet inspection-readiness standards. This includes reviewing Master Manufacturing Records, batch records, specifications, and supplier qualifications. We identify documentation gaps and help implement corrective systems where needed. All compliance records are structured for easy retrieval during audits or investigations.

Step 5 — Post Market Protection

After market entry, we continuously monitor FDA enforcement activity, warning letters, import alerts, and ingredient-specific regulatory trends. We analyze how emerging actions may impact your product category.

If regulatory risks arise, we provide early guidance on claim adjustments, formulation changes, or documentation updates. This allows your brand to adapt before becoming a target.